Effects of magnesium and VE on bioactivity of erythrocyte membrane of people with metabolic syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10001015

Enrollment

Unknown

Registered

2010-09-03

Start date

2009-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolism Syndrome

Interventions

A:VE 100IU/day

B:VE 200IU/day

C:VE 400IU/day

D:VE 400IU+Mg200mg/day

E:Mg200mg/day

F:placebo

Eligibility

Sex/Gender

All

Age

45 Years to 59 Years

Inclusion criteria

Inclusion criteria: Aged 45-59, male or female.

Exclusion criteria

Exclusion criteria: Serious coronary heart disease, surgery, acute and chronic infections or cancer patients.

Design outcomes

Primary

Measure	Time frame
bioactivity of erythrocyte membran;	—

Countries

China

Contacts

Public ContactAi-guo Ma

maiguo@public.ad.sd.cn+86 532 82991518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026